Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetro Matad Regulatory News (MATD)

Share Price Information for Petro Matad (MATD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.70
Ask: 3.90
Change: -0.05 (-1.30%)
Spread: 0.20 (5.405%)
Open: 3.85
High: 3.85
Low: 3.80
Prev. Close: 3.85
MATD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and Total Voting Rights

24 Mar 2017 11:13

RNS Number : 4716A
Petro Matad Limited
24 March 2017
 

24 March 2017

Petro Matad Limited

("Petro Matad" or the "Company")

Directors' Dealings, Issue of Equity and Total Voting Rights

 

Dealings between Concert Party members

Petro Matad announces that on 24 March 2017 Dr Oyungerel Janchiv, a director of Petro Matad, sold 2,500,000 ordinary shares of US$0.01 each in the Company ("Shares") to Petrovis Matad Inc. ("Petrovis"), at 25p per Share. Each of Dr Oyungerel and Petrovis are members of the Petrovis Group Concert Party, as detailed further below.

 

Exercise of Options

Petro Matad further announces that it has issued 429,500 new Shares pursuant to the exercise of options by certain Directors and employees on 24 March 2017. The below table sets out the changes to Directors' shareholdings following the exercise of options:

Director

Options exercised

Exercise price per Share

Resultant shareholding

Percentage holding of enlarged issued share capital

Oyungerel Janchiv*

62,500

£0.11

16,867,946

5.86%

Ridvan Karpuz

75,000

£0.0788

2,021,209

0.70%

Amarzul Tuul

45,000

£0.11

583,334

0.20%

7,000

£0.1975

 

* Dr Oyungerel Janchiv controls more than 20% of Petrovis. Her direct holding in Petro Matad of 16,867,946 Shares (following her share sale to Petrovis and exercise of options) is, for disclosure purposes, aggregated with that of Petrovis under the AIM definition of director's family. The aggregated holding of Dr Oyungerel and Petrovis is 111,552,208 Shares representing 38.74 per cent. of the Company's enlarged issued share capital.

 

Concert Party holding

Following the issue of the new Shares to Dr Oyungerel Janchiv, the Petrovis Group (being Petrovis, its underlying shareholders and their family members) will hold 144,112,822 Shares, representing 50.05 per cent. of the Company's enlarged issued share capital.

 

Application for admission of new Shares

Application has been made for the 429,500 new Shares, which rank pari passu with the Company's existing issued Shares, to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur on 30 March 2017.

 

Total Voting Rights

Following Admission, Petro Matad will have 287,924,275 ordinary shares in issue, which will also represent the total number of voting rights in the Company. No Share are held in Treasury. This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

 

Petro Matad Limited

Ridvan Karpuz, CEO +97 670 141 099 / +97 675 751 099

 

NOMAD and Broker

Stockdale Securities Limited

Richard Johnson / David Coaten +44 (0)20 7601 6100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFZLFLDXFFBBB
Date   Source Headline
17th Apr 20247:00 amRNSNotice of AGM Logistics
3rd Apr 20247:00 amRNSNotice of AGM
1st Mar 202412:14 pmRNSOperational Update
19th Dec 20237:00 amRNSOperational Update
28th Sep 20237:00 amRNSInterim results and Operational Update
10th Jul 20237:00 amRNSOperational Update: Velociraptor-1 well results
6th Jul 20237:00 amRNSOperational Update: Block XX Land Permit
20th Jun 20237:00 amRNSFinal results for year ended 31 December 2022
14th Jun 20237:00 amRNSOperational Update - Spud of Velociraptor-1
31st May 20237:00 amRNSAward of New Options
22nd May 20237:00 amRNSOperational Update
3rd Apr 20237:00 amRNSOperational Update
3rd Mar 202311:05 amRNSSecond Price Monitoring Extn
3rd Mar 202311:00 amRNSPrice Monitoring Extension
15th Feb 202312:25 pmRNSResult of AGM
14th Feb 20237:00 amRNSOperational Update
9th Feb 20237:00 amRNSNotice of AGM Logistics
8th Feb 20237:00 amRNSResult of Retail Offer
3rd Feb 20237:00 amRNSResults of Capital Raise
2nd Feb 20235:02 pmRNSRetail Offer
2nd Feb 20234:41 pmRNSProposed fundraise for a minimum of US$4.0 million
20th Jan 20237:00 amRNSNotice of AGM
19th Jan 20237:00 amRNSChange of Adviser
9th Jan 20239:00 amRNSPrice Monitoring Extension
4th Jan 20232:05 pmRNSSecond Price Monitoring Extn
4th Jan 20232:00 pmRNSPrice Monitoring Extension
3rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
8th Dec 20222:05 pmRNSSecond Price Monitoring Extn
8th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSOperational Update
22nd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results & Operational Update
27th Jun 20227:00 amRNSFinal Results for Year Ended 31 December 2021
5th May 20227:00 amRNSOperational Update
21st Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 202211:32 amRNSInvestor Conference
3rd Mar 20221:08 pmRNSResult of AGM
2nd Mar 20227:00 amRNSNotice of AGM Logistics
25th Feb 20227:00 amRNSOperational Update
7th Feb 20222:30 pmRNSNotice of AGM
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:37 pmRNSPrice Monitoring Extension
19th Jan 20227:18 amRNSProgressive publishes new research
18th Jan 202211:06 amRNSSecond Price Monitoring Extn
18th Jan 202211:00 amRNSPrice Monitoring Extension
15th Dec 20217:00 amRNSConditional Share Awards and Total Voting Rights
7th Dec 20217:00 amRNSOperational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.